Some of the 21st century’s biggest breakthroughs are happening in health care, transforming the way we diagnose, treat and prevent grave diseases. From gene sequencing and proteomics to the prospect of artificial intelligence (AI)-enabled drug discoveries, what seemed like science fiction just a few years ago is increasingly an everyday reality. These advancements are prompting many to call this the…
Artisan Parnters: Investing in Health Care: Beyond the Buzzwords
A financial market resource for the every-day investor and trader.
-
Merrill Lynch: Monetary Tightening Full Speed Ahead
Seth Golden, , Research Reports, 0
Macro Strategy—Powell On A Mission: U.S. policymakers responded to the pandemic shutdowns with the most aggressive fiscal and monetary...
-
VIX Trading: Even The Pros Get It Wrong
Seth Golden, , Research Reports, 0
It can sometimes be a little confusing to the average investor when the media and financial market communities throw...
-
-
Weekly State of the Market: Bulls In Charge
Seth Golden, , Research Reports, 0
Whether we’re talking about socks or stocks, I like buying quality merchandise when it is marked down. ~Warren Buffett...
-
The Leuthold Group: Non-confirmation Of New Highs?
Seth Golden, , Research Reports, 0
The Major Trend Index was unchanged at a High Neutral reading of +1 in the week ended March 1st....
-
Morgan Stanley: Sunday Start | What’s Next in Global Macro
Seth Golden, , Research Reports, 0
The Mid-Cycle Transition Over the past month, we’ve taken a different path than most equity strategists. Rather than getting...
-
J.P. Morgan 2020 Outlook
Seth Golden, , Research Reports, 0
Eye on the Market Outlook 2020J.P. MORGAN ASSET MANAGEMENT Ghosts of Christmas Past. After a very positive year for...
-
Some Light At The End Of The Tunnel For Target And J.C. Penney
Seth Golden, , Research Reports, 0
Retail sales have been a disappointment now for three consecutive months and as such this may lead to downward...
Recent Articles
Featured Products
- JPM Market Recap $0.00
- JPM Research Note $0.00
- JP Morgan Market Volatility Report $0.00